B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Upadacitinib

0 PubMed studies analyzed

Similar Compounds by Shared Targets

The following compounds share molecular targets with Upadacitinib, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

entrectinib
8 shared targets
reversine
6 shared targets
ilorasertib
8 shared targets
tofacitinib
11 shared targets
azd
9 shared targets
abrocitinib
5 shared targets
whi
6 shared targets
delgocitinib
5 shared targets
gandotinib
5 shared targets
baricitinib
9 shared targets
Loading evidence profile...

This evidence profile for Upadacitinib is generated deterministically from 0 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.